CME Group (NASDAQ:CME) Price Target Raised to $316.00

CME Group (NASDAQ:CME) had its price objective raised by analysts at Deutsche Bank Aktiengesellschaft from $312.00 to $316.00 in a report issued on Thursday,MarketScreener reports. The firm currently has a “buy” rating on the financial services provider’s stock. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential upside of 6.26% from the stock’s previous close.

A number of other equities analysts have also issued reports on the company. The Goldman Sachs Group lowered their price target on CME Group from $265.00 to $264.00 and set a “sell” rating on the stock in a report on Wednesday, January 14th. Keefe, Bruyette & Woods boosted their target price on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a report on Monday, October 13th. Argus cut their price objective on shares of CME Group from $308.00 to $295.00 in a research report on Friday, October 31st. UBS Group reissued a “neutral” rating and issued a $310.00 price target on shares of CME Group in a report on Friday. Finally, Piper Sandler raised their target price on CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $297.47.

CME Group Stock Up 0.9%

CME stock opened at $297.38 on Thursday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03. The company’s 50 day moving average price is $276.48 and its 200 day moving average price is $272.84. The firm has a market capitalization of $107.24 billion, a price-to-earnings ratio of 26.65, a PEG ratio of 3.32 and a beta of 0.27. CME Group has a fifty-two week low of $239.70 and a fifty-two week high of $302.20.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.75 by $0.02. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.64 billion. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.52 EPS. On average, equities research analysts anticipate that CME Group will post 10.49 EPS for the current fiscal year.

Insider Buying and Selling at CME Group

In other CME Group news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the transaction, the chief executive officer directly owned 65,804 shares in the company, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director William R. Shepard purchased 251 shares of the business’s stock in a transaction that occurred on Tuesday, December 30th. The stock was acquired at an average price of $278.37 per share, for a total transaction of $69,870.87. Following the acquisition, the director directly owned 258,710 shares of the company’s stock, valued at $72,017,102.70. This trade represents a 0.10% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in CME. Caldwell Trust Co increased its holdings in CME Group by 116.3% in the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after buying an additional 50 shares during the last quarter. Asset Dedication LLC lifted its stake in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 37 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in CME Group during the 3rd quarter valued at about $27,000. FNY Investment Advisers LLC acquired a new stake in shares of CME Group in the fourth quarter valued at approximately $27,000. Finally, Financial Consulate Inc. bought a new stake in shares of CME Group during the third quarter valued at approximately $28,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Q4 results and volumes — CME reported better-than-expected Q4 earnings and rising profits driven by record average daily volume and higher clearing fees, supporting the view that the fee-based franchise is resilient and helped push the stock to a one‑year high. Read More.
• Positive Sentiment: Tokenization & crypto clearing opportunity — CEO Terry Duffy said CME is exploring a proprietary token and is piloting tokenized cash with Google; management is also pushing 24/7 crypto and securities clearing, initiatives that could expand addressable markets and create new fee streams if scaled. Read More.
• Positive Sentiment: Analyst support — Several analysts reiterated positive views (Morgan Stanley maintained Buy) and RBC raised its price target, underscoring confidence in CME’s structural growth and resilient margins. Read More.
• Neutral Sentiment: Market commentary & valuation caution — Some analysts and commentaries acknowledge high quality but urge valuation discipline (Seeking Alpha piece arguing quality alone doesn’t imply immediate buy). Investors should weigh growth optionality against a ~26.6x P/E and elevated expectations. Read More.
• Neutral Sentiment: Small analyst target tweaks — Raymond James trimmed its target by $1 while keeping Outperform; such minor moves reflect fine‑tuning rather than a major change in sentiment. Read More.
• Negative Sentiment: Higher precious‑metals margins — CME raised initial/maintenance margins for gold and silver futures (gold to 9% from 8%; silver to 18% from 15%) to curb volatility. That can reduce volumes and liquidity in those products in the near term and dent related fee revenue. Read More.
• Negative Sentiment: Bearish shop still present — JPMorgan kept an Underweight rating (while nudging its target), signaling some investors and allocators remain cautious about upside from current levels. That may cap near-term multiple expansion. Read More.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.